Plenty of research has identified the crucial part of GPX4 in the susceptibility to drug-mediated ferroptosis in lung cancer, and targeting GPX4 can re-sensitize drug-resistant lung cancer to chemotherapy drugs (Zhang et al., 2022b; Cheng et al., 2023). This evidence concerns the gene GPX4 and lung cancer.